z-logo
open-access-imgOpen Access
Factor VIII, Fibrinogen and Heparin Resistance in COVID-19 Patients with Thromboembolism: How Should We Manage the Anticoagulation Therapy?
Author(s) -
F Savioli,
Maurício Claro,
Fernando José da Silva Ramos,
Laerte Pastore
Publication year - 2022
Publication title -
clinical and applied thrombosis/hemostasis
Language(s) - English
Resource type - Journals
eISSN - 1938-2723
pISSN - 1076-0296
DOI - 10.1177/10760296221087692
Subject(s) - covid-19 , heparin , fibrinogen , medicine , intensive care medicine , virology , disease , infectious disease (medical specialty) , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom